2009
DOI: 10.1186/1748-717x-4-1
|View full text |Cite
|
Sign up to set email alerts
|

Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study

Abstract: Background: A phase III multi-centre randomised trial (ROSEL) has been initiated to establish the role of stereotactic radiotherapy in patients with operable stage IA lung cancer. Due to rapid changes in radiotherapy technology and evolving techniques for image-guided delivery, guidelines had to be developed in order to ensure uniformity in implementation of stereotactic radiotherapy in this multi-centre study.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
174
0
3

Year Published

2009
2009
2021
2021

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 222 publications
(180 citation statements)
references
References 55 publications
3
174
0
3
Order By: Relevance
“…As a conclusion, it is difficult to find an explicit relation for the location of a PTV. The similar behavior of the parameters can also be seen in a comprehensive comparison for the type ‘a’ and type ‘b’ algorithms by Hurkmans et al (8) The results in this study represent mostly the worst case scenario of the discrepancies between the algorithms concerning small targets locating centrally in the lung.…”
Section: Discussionsupporting
confidence: 81%
See 2 more Smart Citations
“…As a conclusion, it is difficult to find an explicit relation for the location of a PTV. The similar behavior of the parameters can also be seen in a comprehensive comparison for the type ‘a’ and type ‘b’ algorithms by Hurkmans et al (8) The results in this study represent mostly the worst case scenario of the discrepancies between the algorithms concerning small targets locating centrally in the lung.…”
Section: Discussionsupporting
confidence: 81%
“…Five to seven or more conformal static treatment fields or arc techniques, such as volumetric‐modulated arc therapy (VMAT), enable rapid dose falloff away from target, which spares the normal tissue around the PTV. The history, development, and application of SBRT has been thoroughly presented in several review articles, 2 , 3 clinical trial and protocol reports, 4 , 5 , 6 , 7 , 8 and other comprehensive papers (9) by numerous research groups.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…where in 89.5% of cases a 7 field, all coplanar technique had 2 or less minor deviations 16. They too accounted for heterogeneity correction, but used the less stringent intermediate dose constraints from the ROSEL trial 18. The difference in intermediate dose constraints between RTOG 1021 and ROSEL significantly alters which beam arrangements are deemed acceptable.…”
Section: Discussionmentioning
confidence: 99%
“…report that in 17 of 19 cases, seven equidistant coplanar fields produced no more than two minor deviations. This group, however, used high‐ and intermediate dose constraints from the ROSEL study,18 which are more relaxed than those of RTOG. Furthermore, both Lim et al 15.…”
Section: Introductionmentioning
confidence: 99%